nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Vaginal infection—Mesalazine—Crohn's disease	0.00626	0.00626	CcSEcCtD
Acamprosate—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00609	0.00609	CcSEcCtD
Acamprosate—Fracture—Prednisone—Crohn's disease	0.00604	0.00604	CcSEcCtD
Acamprosate—Multiple fractures—Prednisone—Crohn's disease	0.00604	0.00604	CcSEcCtD
Acamprosate—Ecchymosis—Mesalazine—Crohn's disease	0.00599	0.00599	CcSEcCtD
Acamprosate—Mouth ulceration—Mesalazine—Crohn's disease	0.00599	0.00599	CcSEcCtD
Acamprosate—Lymphadenopathy—Mesalazine—Crohn's disease	0.00564	0.00564	CcSEcCtD
Acamprosate—Immune system disorder—Mercaptopurine—Crohn's disease	0.00554	0.00554	CcSEcCtD
Acamprosate—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00553	0.00553	CcSEcCtD
Acamprosate—Hypothyroidism—Prednisone—Crohn's disease	0.00546	0.00546	CcSEcCtD
Acamprosate—Gastroenteritis—Mesalazine—Crohn's disease	0.00543	0.00543	CcSEcCtD
Acamprosate—Alopecia—Mercaptopurine—Crohn's disease	0.00542	0.00542	CcSEcCtD
Acamprosate—Deafness—Mesalazine—Crohn's disease	0.00538	0.00538	CcSEcCtD
Acamprosate—Eczema—Mesalazine—Crohn's disease	0.00536	0.00536	CcSEcCtD
Acamprosate—Malnutrition—Mercaptopurine—Crohn's disease	0.00534	0.00534	CcSEcCtD
Acamprosate—Renal failure acute—Mesalazine—Crohn's disease	0.00521	0.00521	CcSEcCtD
Acamprosate—Libido decreased—Mesalazine—Crohn's disease	0.00519	0.00519	CcSEcCtD
Acamprosate—Increased appetite—Mesalazine—Crohn's disease	0.00512	0.00512	CcSEcCtD
Acamprosate—Thirst—Mesalazine—Crohn's disease	0.00506	0.00506	CcSEcCtD
Acamprosate—Dermatitis bullous—Mesalazine—Crohn's disease	0.00504	0.00504	CcSEcCtD
Acamprosate—Suicidal ideation—Prednisone—Crohn's disease	0.005	0.005	CcSEcCtD
Acamprosate—Myopathy—Prednisone—Crohn's disease	0.005	0.005	CcSEcCtD
Acamprosate—Arthritis—Mesalazine—Crohn's disease	0.00495	0.00495	CcSEcCtD
Acamprosate—Anaemia—Mercaptopurine—Crohn's disease	0.00494	0.00494	CcSEcCtD
Acamprosate—Mania—Prednisone—Crohn's disease	0.00482	0.00482	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00481	0.00481	CcSEcCtD
Acamprosate—Leukopenia—Mercaptopurine—Crohn's disease	0.00478	0.00478	CcSEcCtD
Acamprosate—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00477	0.00477	CcSEcCtD
Acamprosate—Migraine—Mesalazine—Crohn's disease	0.00474	0.00474	CcSEcCtD
Acamprosate—Face oedema—Mesalazine—Crohn's disease	0.00465	0.00465	CcSEcCtD
Acamprosate—Arthralgia—Mercaptopurine—Crohn's disease	0.00455	0.00455	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00452	0.00452	CcSEcCtD
Acamprosate—Blood creatinine increased—Mesalazine—Crohn's disease	0.00451	0.00451	CcSEcCtD
Acamprosate—Pancreatitis—Azathioprine—Crohn's disease	0.00448	0.00448	CcSEcCtD
Acamprosate—Liver function test abnormal—Mesalazine—Crohn's disease	0.00444	0.00444	CcSEcCtD
Acamprosate—Abscess—Prednisone—Crohn's disease	0.00443	0.00443	CcSEcCtD
Acamprosate—Dry skin—Mesalazine—Crohn's disease	0.00441	0.00441	CcSEcCtD
Acamprosate—Orthostatic hypotension—Mesalazine—Crohn's disease	0.0044	0.0044	CcSEcCtD
Acamprosate—Breast disorder—Mesalazine—Crohn's disease	0.00435	0.00435	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00433	0.00433	CcSEcCtD
Acamprosate—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00427	0.00427	CcSEcCtD
Acamprosate—Gastritis—Mesalazine—Crohn's disease	0.00426	0.00426	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00424	0.00424	CcSEcCtD
Acamprosate—Skin disorder—Mercaptopurine—Crohn's disease	0.00423	0.00423	CcSEcCtD
Acamprosate—Abdominal distension—Mesalazine—Crohn's disease	0.00419	0.00419	CcSEcCtD
Acamprosate—Asthma—Mesalazine—Crohn's disease	0.00416	0.00416	CcSEcCtD
Acamprosate—Dysphagia—Mesalazine—Crohn's disease	0.00416	0.00416	CcSEcCtD
Acamprosate—Influenza—Mesalazine—Crohn's disease	0.00416	0.00416	CcSEcCtD
Acamprosate—Anorexia—Mercaptopurine—Crohn's disease	0.00415	0.00415	CcSEcCtD
Acamprosate—Eosinophilia—Mesalazine—Crohn's disease	0.00412	0.00412	CcSEcCtD
Acamprosate—Pneumonia—Azathioprine—Crohn's disease	0.0041	0.0041	CcSEcCtD
Acamprosate—Pancreatitis—Mesalazine—Crohn's disease	0.00408	0.00408	CcSEcCtD
Acamprosate—Angina pectoris—Mesalazine—Crohn's disease	0.00405	0.00405	CcSEcCtD
Acamprosate—Bronchitis—Mesalazine—Crohn's disease	0.004	0.004	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00397	0.00397	CcSEcCtD
Acamprosate—Pollakiuria—Mesalazine—Crohn's disease	0.00384	0.00384	CcSEcCtD
Acamprosate—Photosensitivity reaction—Mesalazine—Crohn's disease	0.0038	0.0038	CcSEcCtD
Acamprosate—Decreased appetite—Mercaptopurine—Crohn's disease	0.00379	0.00379	CcSEcCtD
Acamprosate—Weight increased—Mesalazine—Crohn's disease	0.00379	0.00379	CcSEcCtD
Acamprosate—Weight decreased—Mesalazine—Crohn's disease	0.00376	0.00376	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00376	0.00376	CcSEcCtD
Acamprosate—Pneumonia—Mesalazine—Crohn's disease	0.00373	0.00373	CcSEcCtD
Acamprosate—Depression—Mesalazine—Crohn's disease	0.0037	0.0037	CcSEcCtD
Acamprosate—Haemoglobin—Azathioprine—Crohn's disease	0.00367	0.00367	CcSEcCtD
Acamprosate—Haemorrhage—Azathioprine—Crohn's disease	0.00366	0.00366	CcSEcCtD
Acamprosate—Stomatitis—Mesalazine—Crohn's disease	0.00362	0.00362	CcSEcCtD
Acamprosate—Urinary tract infection—Mesalazine—Crohn's disease	0.00361	0.00361	CcSEcCtD
Acamprosate—Sweating—Mesalazine—Crohn's disease	0.00356	0.00356	CcSEcCtD
Acamprosate—Haematuria—Mesalazine—Crohn's disease	0.00354	0.00354	CcSEcCtD
Acamprosate—Epistaxis—Mesalazine—Crohn's disease	0.0035	0.0035	CcSEcCtD
Acamprosate—Body temperature increased—Mercaptopurine—Crohn's disease	0.00345	0.00345	CcSEcCtD
Acamprosate—Haemoglobin—Mesalazine—Crohn's disease	0.00335	0.00335	CcSEcCtD
Acamprosate—Rhinitis—Mesalazine—Crohn's disease	0.00334	0.00334	CcSEcCtD
Acamprosate—Haemorrhage—Mesalazine—Crohn's disease	0.00333	0.00333	CcSEcCtD
Acamprosate—Hepatitis—Mesalazine—Crohn's disease	0.00333	0.00333	CcSEcCtD
Acamprosate—Pharyngitis—Mesalazine—Crohn's disease	0.0033	0.0033	CcSEcCtD
Acamprosate—Immune system disorder—Azathioprine—Crohn's disease	0.0033	0.0033	CcSEcCtD
Acamprosate—Oedema peripheral—Mesalazine—Crohn's disease	0.00328	0.00328	CcSEcCtD
Acamprosate—Chills—Azathioprine—Crohn's disease	0.00328	0.00328	CcSEcCtD
Acamprosate—Alopecia—Azathioprine—Crohn's disease	0.00323	0.00323	CcSEcCtD
Acamprosate—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00321	0.00321	CcSEcCtD
Acamprosate—Oesophagitis—Prednisone—Crohn's disease	0.00321	0.00321	CcSEcCtD
Acamprosate—Ecchymosis—Prednisone—Crohn's disease	0.00317	0.00317	CcSEcCtD
Acamprosate—Tinnitus—Mesalazine—Crohn's disease	0.0031	0.0031	CcSEcCtD
Acamprosate—Hyperkinesia—Prednisone—Crohn's disease	0.00306	0.00306	CcSEcCtD
Acamprosate—Immune system disorder—Mesalazine—Crohn's disease	0.00301	0.00301	CcSEcCtD
Acamprosate—Chills—Mesalazine—Crohn's disease	0.00299	0.00299	CcSEcCtD
Acamprosate—Diarrhoea—Mercaptopurine—Crohn's disease	0.00298	0.00298	CcSEcCtD
Acamprosate—Ill-defined disorder—Azathioprine—Crohn's disease	0.00295	0.00295	CcSEcCtD
Acamprosate—Alopecia—Mesalazine—Crohn's disease	0.00294	0.00294	CcSEcCtD
Acamprosate—Thrombophlebitis—Prednisone—Crohn's disease	0.00294	0.00294	CcSEcCtD
Acamprosate—Anaemia—Azathioprine—Crohn's disease	0.00294	0.00294	CcSEcCtD
Acamprosate—Diabetes mellitus—Prednisone—Crohn's disease	0.00293	0.00293	CcSEcCtD
Acamprosate—Mental disorder—Mesalazine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Acamprosate—Malaise—Azathioprine—Crohn's disease	0.00287	0.00287	CcSEcCtD
Acamprosate—Flatulence—Mesalazine—Crohn's disease	0.00286	0.00286	CcSEcCtD
Acamprosate—Leukopenia—Azathioprine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Acamprosate—Tension—Mesalazine—Crohn's disease	0.00284	0.00284	CcSEcCtD
Acamprosate—Dysgeusia—Mesalazine—Crohn's disease	0.00284	0.00284	CcSEcCtD
Acamprosate—Nervousness—Mesalazine—Crohn's disease	0.00282	0.00282	CcSEcCtD
Acamprosate—Back pain—Mesalazine—Crohn's disease	0.0028	0.0028	CcSEcCtD
Acamprosate—Muscle spasms—Mesalazine—Crohn's disease	0.00279	0.00279	CcSEcCtD
Acamprosate—Vomiting—Mercaptopurine—Crohn's disease	0.00277	0.00277	CcSEcCtD
Acamprosate—Injury—Prednisone—Crohn's disease	0.00277	0.00277	CcSEcCtD
Acamprosate—Rash—Mercaptopurine—Crohn's disease	0.00275	0.00275	CcSEcCtD
Acamprosate—Dermatitis—Mercaptopurine—Crohn's disease	0.00275	0.00275	CcSEcCtD
Acamprosate—Tremor—Mesalazine—Crohn's disease	0.00272	0.00272	CcSEcCtD
Acamprosate—Amnesia—Prednisone—Crohn's disease	0.00271	0.00271	CcSEcCtD
Acamprosate—Increased appetite—Prednisone—Crohn's disease	0.00271	0.00271	CcSEcCtD
Acamprosate—Arthralgia—Azathioprine—Crohn's disease	0.00271	0.00271	CcSEcCtD
Acamprosate—Myalgia—Azathioprine—Crohn's disease	0.00271	0.00271	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00269	0.00269	CcSEcCtD
Acamprosate—Ill-defined disorder—Mesalazine—Crohn's disease	0.00269	0.00269	CcSEcCtD
Acamprosate—Anaemia—Mesalazine—Crohn's disease	0.00268	0.00268	CcSEcCtD
Acamprosate—Discomfort—Azathioprine—Crohn's disease	0.00268	0.00268	CcSEcCtD
Acamprosate—Angioedema—Mesalazine—Crohn's disease	0.00265	0.00265	CcSEcCtD
Acamprosate—Malaise—Mesalazine—Crohn's disease	0.00261	0.00261	CcSEcCtD
Acamprosate—Cardiac failure—Prednisone—Crohn's disease	0.00261	0.00261	CcSEcCtD
Acamprosate—Vertigo—Mesalazine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Acamprosate—Syncope—Mesalazine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Acamprosate—Leukopenia—Mesalazine—Crohn's disease	0.00259	0.00259	CcSEcCtD
Acamprosate—Nausea—Mercaptopurine—Crohn's disease	0.00259	0.00259	CcSEcCtD
Acamprosate—Infection—Azathioprine—Crohn's disease	0.00258	0.00258	CcSEcCtD
Acamprosate—Palpitations—Mesalazine—Crohn's disease	0.00256	0.00256	CcSEcCtD
Acamprosate—Loss of consciousness—Mesalazine—Crohn's disease	0.00255	0.00255	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00255	0.00255	CcSEcCtD
Acamprosate—Thrombocytopenia—Azathioprine—Crohn's disease	0.00254	0.00254	CcSEcCtD
Acamprosate—Cough—Mesalazine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Acamprosate—Skin disorder—Azathioprine—Crohn's disease	0.00252	0.00252	CcSEcCtD
Acamprosate—Hypertension—Mesalazine—Crohn's disease	0.0025	0.0025	CcSEcCtD
Acamprosate—Psychotic disorder—Prednisone—Crohn's disease	0.00249	0.00249	CcSEcCtD
Acamprosate—Arthralgia—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Acamprosate—Myalgia—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Acamprosate—Chest pain—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Acamprosate—Anxiety—Mesalazine—Crohn's disease	0.00246	0.00246	CcSEcCtD
Acamprosate—Face oedema—Prednisone—Crohn's disease	0.00246	0.00246	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00245	0.00245	CcSEcCtD
Acamprosate—Discomfort—Mesalazine—Crohn's disease	0.00244	0.00244	CcSEcCtD
Acamprosate—Hypotension—Azathioprine—Crohn's disease	0.00243	0.00243	CcSEcCtD
Acamprosate—Dry mouth—Mesalazine—Crohn's disease	0.00241	0.00241	CcSEcCtD
Acamprosate—Confusional state—Mesalazine—Crohn's disease	0.00239	0.00239	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00237	0.00237	CcSEcCtD
Acamprosate—Anaphylactic shock—Mesalazine—Crohn's disease	0.00237	0.00237	CcSEcCtD
Acamprosate—Infection—Mesalazine—Crohn's disease	0.00235	0.00235	CcSEcCtD
Acamprosate—Dry skin—Prednisone—Crohn's disease	0.00233	0.00233	CcSEcCtD
Acamprosate—Shock—Mesalazine—Crohn's disease	0.00233	0.00233	CcSEcCtD
Acamprosate—Thrombocytopenia—Mesalazine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Acamprosate—Tachycardia—Mesalazine—Crohn's disease	0.00231	0.00231	CcSEcCtD
Acamprosate—Skin disorder—Mesalazine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Acamprosate—Hyperhidrosis—Mesalazine—Crohn's disease	0.00229	0.00229	CcSEcCtD
Acamprosate—Anorexia—Mesalazine—Crohn's disease	0.00225	0.00225	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00225	0.00225	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00224	0.00224	CcSEcCtD
Acamprosate—Abdominal distension—Prednisone—Crohn's disease	0.00222	0.00222	CcSEcCtD
Acamprosate—Hypotension—Mesalazine—Crohn's disease	0.00221	0.00221	CcSEcCtD
Acamprosate—Pancreatitis—Prednisone—Crohn's disease	0.00216	0.00216	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00216	0.00216	CcSEcCtD
Acamprosate—Feeling abnormal—Azathioprine—Crohn's disease	0.00214	0.00214	CcSEcCtD
Acamprosate—Insomnia—Mesalazine—Crohn's disease	0.00214	0.00214	CcSEcCtD
Acamprosate—Paraesthesia—Mesalazine—Crohn's disease	0.00212	0.00212	CcSEcCtD
Acamprosate—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00212	0.00212	CcSEcCtD
Acamprosate—Dyspnoea—Mesalazine—Crohn's disease	0.00211	0.00211	CcSEcCtD
Acamprosate—Somnolence—Mesalazine—Crohn's disease	0.0021	0.0021	CcSEcCtD
Acamprosate—Dyspepsia—Mesalazine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Acamprosate—Decreased appetite—Mesalazine—Crohn's disease	0.00206	0.00206	CcSEcCtD
Acamprosate—Body temperature increased—Azathioprine—Crohn's disease	0.00205	0.00205	CcSEcCtD
Acamprosate—Abdominal pain—Azathioprine—Crohn's disease	0.00205	0.00205	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00204	0.00204	CcSEcCtD
Acamprosate—Erectile dysfunction—Prednisone—Crohn's disease	0.00203	0.00203	CcSEcCtD
Acamprosate—Pain—Mesalazine—Crohn's disease	0.00202	0.00202	CcSEcCtD
Acamprosate—Constipation—Mesalazine—Crohn's disease	0.00202	0.00202	CcSEcCtD
Acamprosate—Weight increased—Prednisone—Crohn's disease	0.002	0.002	CcSEcCtD
Acamprosate—Weight decreased—Prednisone—Crohn's disease	0.00199	0.00199	CcSEcCtD
Acamprosate—Hyperglycaemia—Prednisone—Crohn's disease	0.00199	0.00199	CcSEcCtD
Acamprosate—Depression—Prednisone—Crohn's disease	0.00196	0.00196	CcSEcCtD
Acamprosate—Feeling abnormal—Mesalazine—Crohn's disease	0.00195	0.00195	CcSEcCtD
Acamprosate—Acute coronary syndrome—Prednisone—Crohn's disease	0.00193	0.00193	CcSEcCtD
Acamprosate—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00193	0.00193	CcSEcCtD
Acamprosate—Myocardial infarction—Prednisone—Crohn's disease	0.00192	0.00192	CcSEcCtD
Acamprosate—Hypersensitivity—Azathioprine—Crohn's disease	0.00191	0.00191	CcSEcCtD
Acamprosate—Urticaria—Mesalazine—Crohn's disease	0.00188	0.00188	CcSEcCtD
Acamprosate—Abdominal pain—Mesalazine—Crohn's disease	0.00187	0.00187	CcSEcCtD
Acamprosate—Body temperature increased—Mesalazine—Crohn's disease	0.00187	0.00187	CcSEcCtD
Acamprosate—Diarrhoea—Azathioprine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Acamprosate—Haemoglobin—Prednisone—Crohn's disease	0.00177	0.00177	CcSEcCtD
Acamprosate—Haemorrhage—Prednisone—Crohn's disease	0.00176	0.00176	CcSEcCtD
Acamprosate—Hallucination—Prednisone—Crohn's disease	0.00175	0.00175	CcSEcCtD
Acamprosate—Hypersensitivity—Mesalazine—Crohn's disease	0.00174	0.00174	CcSEcCtD
Acamprosate—Dizziness—Azathioprine—Crohn's disease	0.00172	0.00172	CcSEcCtD
Acamprosate—Asthenia—Mesalazine—Crohn's disease	0.0017	0.0017	CcSEcCtD
Acamprosate—Pruritus—Mesalazine—Crohn's disease	0.00167	0.00167	CcSEcCtD
Acamprosate—Vomiting—Azathioprine—Crohn's disease	0.00165	0.00165	CcSEcCtD
Acamprosate—Rash—Azathioprine—Crohn's disease	0.00164	0.00164	CcSEcCtD
Acamprosate—Dermatitis—Azathioprine—Crohn's disease	0.00164	0.00164	CcSEcCtD
Acamprosate—Headache—Azathioprine—Crohn's disease	0.00163	0.00163	CcSEcCtD
Acamprosate—Diarrhoea—Mesalazine—Crohn's disease	0.00162	0.00162	CcSEcCtD
Acamprosate—Immune system disorder—Prednisone—Crohn's disease	0.00159	0.00159	CcSEcCtD
Acamprosate—Dizziness—Mesalazine—Crohn's disease	0.00156	0.00156	CcSEcCtD
Acamprosate—Alopecia—Prednisone—Crohn's disease	0.00156	0.00156	CcSEcCtD
Acamprosate—Mental disorder—Prednisone—Crohn's disease	0.00154	0.00154	CcSEcCtD
Acamprosate—Nausea—Azathioprine—Crohn's disease	0.00154	0.00154	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—Crohn's disease	0.00153	0.00153	CcSEcCtD
Acamprosate—Vomiting—Mesalazine—Crohn's disease	0.0015	0.0015	CcSEcCtD
Acamprosate—Rash—Mesalazine—Crohn's disease	0.00149	0.00149	CcSEcCtD
Acamprosate—Dermatitis—Mesalazine—Crohn's disease	0.00149	0.00149	CcSEcCtD
Acamprosate—Headache—Mesalazine—Crohn's disease	0.00148	0.00148	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—Crohn's disease	0.00142	0.00142	CcSEcCtD
Acamprosate—Anaemia—Prednisone—Crohn's disease	0.00142	0.00142	CcSEcCtD
Acamprosate—Agitation—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Acamprosate—Nausea—Mesalazine—Crohn's disease	0.00141	0.00141	CcSEcCtD
Acamprosate—Angioedema—Prednisone—Crohn's disease	0.0014	0.0014	CcSEcCtD
Acamprosate—Malaise—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Acamprosate—Vertigo—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Acamprosate—Syncope—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—Crohn's disease	0.00135	0.00135	CcSEcCtD
Acamprosate—Convulsion—Prednisone—Crohn's disease	0.00133	0.00133	CcSEcCtD
Acamprosate—Hypertension—Prednisone—Crohn's disease	0.00132	0.00132	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—Crohn's disease	0.00131	0.00131	CcSEcCtD
Acamprosate—Myalgia—Prednisone—Crohn's disease	0.00131	0.00131	CcSEcCtD
Acamprosate—Anxiety—Prednisone—Crohn's disease	0.0013	0.0013	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.0013	0.0013	CcSEcCtD
Acamprosate—Discomfort—Prednisone—Crohn's disease	0.00129	0.00129	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—Crohn's disease	0.00125	0.00125	CcSEcCtD
Acamprosate—Infection—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Acamprosate—Shock—Prednisone—Crohn's disease	0.00123	0.00123	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—Crohn's disease	0.00122	0.00122	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—Crohn's disease	0.00122	0.00122	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—Crohn's disease	0.00121	0.00121	CcSEcCtD
Acamprosate—Anorexia—Prednisone—Crohn's disease	0.00119	0.00119	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00114	0.00114	CcSEcCtD
Acamprosate—Insomnia—Prednisone—Crohn's disease	0.00113	0.00113	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—Crohn's disease	0.00109	0.00109	CcSEcCtD
Acamprosate—Constipation—Prednisone—Crohn's disease	0.00107	0.00107	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisone—Crohn's disease	0.00103	0.00103	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—Crohn's disease	0.00102	0.00102	CcSEcCtD
Acamprosate—Urticaria—Prednisone—Crohn's disease	0.000994	0.000994	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—Crohn's disease	0.000989	0.000989	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—Crohn's disease	0.000989	0.000989	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisone—Crohn's disease	0.000922	0.000922	CcSEcCtD
Acamprosate—Asthenia—Prednisone—Crohn's disease	0.000898	0.000898	CcSEcCtD
Acamprosate—Pruritus—Prednisone—Crohn's disease	0.000885	0.000885	CcSEcCtD
Acamprosate—Diarrhoea—Prednisone—Crohn's disease	0.000856	0.000856	CcSEcCtD
Acamprosate—Dizziness—Prednisone—Crohn's disease	0.000828	0.000828	CcSEcCtD
Acamprosate—Vomiting—Prednisone—Crohn's disease	0.000796	0.000796	CcSEcCtD
Acamprosate—Rash—Prednisone—Crohn's disease	0.000789	0.000789	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—Crohn's disease	0.000788	0.000788	CcSEcCtD
Acamprosate—Headache—Prednisone—Crohn's disease	0.000784	0.000784	CcSEcCtD
Acamprosate—Nausea—Prednisone—Crohn's disease	0.000743	0.000743	CcSEcCtD
